PCP
GBT

Proficio Capital Partners’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Proficio Capital Partners’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-18
Closed -$1K – 1732
2019
Q2 		$1K Hold
18
– – ﹤0.01% 1866
2019
Q1 		$1K Buy
+18
New +$885 ﹤0.01% 1639

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Proficio Capital Partners's GBT Position: Q3 2019 in Review

Proficio Capital Partners sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2019, closing a stake of 18 shares — an estimated $1K sold.

Proficio Capital Partners first reported a position in GBT in Q1 2019 and held it in 2 quarters. The position peaked at $1K in Q2 2019. 208 funds tracked by Wall St. Rank hold GBT as of Q3 2019.

  • Proficio Capital Partners reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
  • Proficio Capital Partners sold 18 Global Blood Therapeutics, Inc. shares in Q3 2019, an estimated $1K.
  • Proficio Capital Partners first reported a position in Global Blood Therapeutics, Inc. in Q1 2019 and held it in 2 quarters.
  • Proficio Capital Partners's Global Blood Therapeutics, Inc. position peaked at $1K in Q2 2019.
  • 208 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2019.

Based on Proficio Capital Partners's 13F filing for Q3 2019, filed 13 Nov 2019.